Abstract
Bone loss and subclinical diabetes-like conditions are developed during long-term spaceflight. Recently, it was demonstrated that bone was able to regulate energy metabolism and testosterone synthesis via osteocalcin. In this study, we analyzed the changes of bone metabolism and glycolipid metabolism of rhesus and their association (P < 0.05). Serum insulin and LDL content significantly decreased at 7 days and remained at a low level, and the blood glucose level showed a significant decline at 7 days, but recovery at 21 days. The correlation analysis showed that there was a correlation between osteocalcin and blood glucose, cortisol and HDL. The experimental results show that there is mutual regulation between bone and glycolipid metabolism in the bedrest experiment of rhesus.
Introduction
Astronauts on extended space missions face significant physiological challenges, most notably a rapid loss of bone density (1-2% per month) and shifts in energy metabolism that often present as subclinical diabetes. Historically, bone was viewed merely as a structural scaffold. However, recent biological discoveries have revealed that bone functions as an endocrine organ, regulating energy metabolism and testosterone synthesis via the protein osteocalcin.
While this endocrine function is documented on Earth, the impact of microgravity on this bone-metabolism feedback loop remains poorly understood. This study utilizes a non-human primate model (rhesus monkeys) to investigate the interconnected degradation of bone and glycolipid (sugar and fat) metabolism under simulated spaceflight conditions, addressing the physiological differences between rodents and humans.
Methods
To simulate the fluid shifts and mechanical unloading experienced during spaceflight, researchers employed a Head-Down Bed Rest (HDBR) model.
- Experimental Design: Nine rhesus monkeys completed a 42-day trial involving a -10° head-down tilt. The cohort was divided into a control group (n=4) and an experimental bed-rest group (n=5).
- Biomarker Analysis: Blood serum was collected at baseline (day -3) and during the bed rest period at days 7, 21, and 35.
- Assays: The study measured markers for bone formation (Bone Alkaline Phosphatase, BAP), bone resorption (Tartrate-Resistant Acid Phosphatase, TRAP), and bone endocrine function (Osteocalcin). Metabolic markers including Glucose, Insulin, Cortisol, HDL, and LDL were also tracked.
- Statistical Analysis: Pearson and Spearman correlation analyses were performed to map relationships between bone and metabolic markers over time.
Results
The simulated microgravity environment led to significant suppression of both bone and metabolic markers.
- Bone Metabolism Suppression: Serum BAP, a marker of bone formation, dropped to approximately 60% of the control group's levels and remained suppressed throughout the trial. Osteocalcin levels similarly showed a significant decrease.
- Metabolic Shifts: Serum insulin and LDL cholesterol decreased significantly by day 7 and remained low. Blood glucose levels dropped initially at day 7 but showed signs of recovery by day 21, suggesting a physiological attempt to adapt to the new environment.
- Correlation Analysis: Statistical analysis revealed critical links: osteocalcin was negatively correlated with blood glucose ($r = -0.543, P = 0.001$) and positively correlated with cortisol ($r = 0.430, P = 0.006$) and HDL ($r = 0.334, P = 0.035$).
Discussion
The findings reinforce the paradigm that bones actively drive metabolism. The strong correlation between bone-derived osteocalcin and metabolic markers suggests that spaceflight-induced insulin and glucose issues may be directly linked to the suppression of bone formation. Furthermore, the positive correlation between cortisol and osteocalcin suggests that the physiological stress of immobilization and fluid shifts is deeply intertwined with skeletal endocrine signaling.
Limitations and Future Work
The study's primary limitation is the small sample size (n=9), which is typical for primate research but limits statistical power. Future research should focus on the undercarboxylated form of osteocalcin—the active endocrine variant—to better understand its potential as a therapeutic target for regulating energy, fertility, and brain function during long-duration space exploration.
Summary updated